ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Rigshospitalet (Copenhagen University Hospital) at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Rigshospitalet (Copenhagen University Hospital) takes part in 8 sessions at ESMO 2026 in Madrid. Its program covers precision treatment and outcomes across gastrointestinal, gynaecological and other cancers. It reports a trial of olaparib, durvalumab and a vaccine as maintenance treatment for recurrent ovarian cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
Rigshospitalet (Copenhagen University Hospital) Copenhagen, Denmark | |
National university hospital of Denmark in Copenhagen, affiliated with the University of Copenhagen. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 A signal-seeking study of niraparib efficacy outside current drug label in patients with advanced cancer: Results from the Danish ProTarget precision oncology trial Sarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 15:15–16:00 Abstract Fri Oct 23 16:37–16:42 Abstract Sun Oct 25 09:18–09:28 Poster Sun Oct 25 12:00–12:45 Talk Mon Oct 26 08:30–08:50 Chair Mon Oct 26 08:30–10:00 Poster Mon Oct 26 12:00–12:45 |
Find decision makers at Rigshospitalet (Copenhagen University Hospital)
Tell us what you sell and we’ll find the people at Rigshospitalet (Copenhagen University Hospital) most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction